552
Views
8
CrossRef citations to date
0
Altmetric
ARTICLES

Ten Years of Abstinence in Former Opiate Addicts: Medication-Free Non-Patients Compared to Methadone Maintenance Patients

, PhD, , MA, , MD, , MD, , MD & , MD

REFERENCES

  • National Institutes of Health (NIH). NIH Consensus Statement, 17–19 November. Effective medical treatment of opiate addiction. Bethesda, MD: NIH 1997; 15:1–38.
  • DSM-IV-TR. 2000; 276–7 pp. Arlington, VA: American Psychiatric Association.
  • Haastrup S, Jepsen PW. Seven year follow-up of 300 young drug abusers. Acta Psychiatr Scand 1984; 70:503–9.
  • Haastrup S, Jepsen PW. Eleven year follow-up of 300 young opioid addicts. Acta Psychiatr Scand 1988; 74:22–6.
  • Hser YI, Anglin D, Powers K. A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry 1993; 50:577–84.
  • Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001; 58:503–8.
  • Simpson DD, Savage LJ. Treatment re-entry and outcomes of opioid addicts during a four-year follow-up after drug abuse treatment in the United States. Bull Narc 1980; 32:1–10.
  • Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment. A national study of effectiveness. Chapel Hill, NC: The University of North Carolina Press, 1989.
  • Hser YI, Anglin MD, Fletcher B. Comparative treatment effectiveness. Effects of program modality and client drug dependence history on drug use reduction. J Subst Abuse Treat 1998; 15:513–23.
  • Teesson M, Ross J, Darke S, et al. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2006; 83:174–80.
  • Scherbaum N, Specka M. Factors influencing the course of opiate addiction. Int J Methods Psychiatr Res 2008; 17:S39–44.
  • Stein MD, Herman DS, Bishop S, et al. Sleep disturbance among methadone maintained patients. J Subst Abuse Treat 2004; 26:175–80.
  • Peles E, Schreiber S, Adelson M. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol 2009; 19:581–8.
  • Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003; 289:2370–8.
  • Peles E, Schreiber S, Gordon J, Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 2005; 113:340–6.
  • Wang GY, Wouldes TA, Russell BB. Methadone maintenance treatment and cognitive function: a systematic review. Curr Drug Abuse Rev 2013; 6: 220–30.
  • Mansukhani MP, Kolla BP, Surani S, Varon J, Ramar K. Sleep deprivation in resident physicians, work hour limitations, and related outcomes: a systematic review of the literature. Postgrad Med 2012; 124:241–9.
  • Peles E, Schreiber S, Domany Y, Sason A, Tene O, Adelson M. Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients. W J Biol Psychiatry 2014; 15: 629–35.
  • Kellogg SH, McHugh PF, Bell K, et al. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 2003; 69:137–50.
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193–213.
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540–5.
  • Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000; 15:548–61.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state:” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–98.
  • Hawks RL. Analytical methodology. NIDA Res Monogr 1986; 73:30–42.
  • van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth 2013; 111:13–8.
  • Soares CN, Murray BJ. Sleep disorders in women: clinical evidence and treatment strategies. Psychiatr Clin North Am 2006; 29:1095–113.
  • Bramness JG, Kornør H. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend 2007; 90:203–9.
  • Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis 2008; 27:37–48.
  • Peles E, Schreiber S, Adelson M. Fifteen-year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend 2010; 107:141–8.
  • Turk DC, Cohen MJ. Sleep as a marker in the effective management of chronic osteoarthritis pain with opioid analgesics. Semin Arthritis Rheum 2010; 39:477e90.
  • Sewlall S, Pillay V, Danckwerts MP, et al. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv 2010; 7:370e88.
  • Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol 2012; 8:387–92.
  • Compton P, Canamar CP, Hillhouse M, Ling W. Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. J Pain 2012; 13:401–9.
  • Stamer UM, Stüber F. Genetic factors in pain and its treatment. Curr Opin Anaesthesiol 2007; 20:478–84.
  • Diamond A. Executive functions. Annu Rev Psychol 2013; 64:135–68.
  • Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol 2014; 13:1017–28.
  • Wilckens KA, Woo SG, Kirk AR, Erickson KI, Wheeler ME. Role of sleep continuity and total sleep time in executive function across the adult lifespan. Psychol Aging 2014; 29:658–65.
  • Adelson M, Schreiber S, Sason A, Peles E. Are 2 weeks of “take-home” privileges beneficial for patients' long-term outcome in a methadone maintenance treatment program? J Addict Med 2014; 8:170–5.
  • Best DW, Ghufran S, Day E, Ray R, Loaring J. Breaking the habit: a retrospective analysis of desistance factors among formerly problematic heroin users. Drug Alcohol Rev 2008; 27:619–24.
  • Kreek MJ, Wardlaw SL, Hartman N, et al. Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sci 1983; 33:409–11.
  • Hser YI. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis 2007; 26:51–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.